We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.8B
Cap. Flow %
-1.49%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.18%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JYNT icon
2976
The Joint Corp
JYNT
$116M
– –
-5,756
Closed -$204K
KRNT icon
2977
Kornit Digital
KRNT
$669M
– –
-5,400
Closed -$447K
KROS icon
2978
Keros Therapeutics
KROS
$230M
– –
-4,505
Closed -$245K
LOVE
2979
LoveSac
LOVE
$219M
– –
-4,554
Closed -$246K
MCFT icon
2980
MasterCraft Boat Holdings
MCFT
$501M
– –
-8,467
Closed -$208K
LITS
2981
Lite Strategy Inc
LITS
$49M
– –
-516
Closed -$6K
METC icon
2982
Ramaco Resources Class A
METC
$574M
– –
-157,956
Closed -$2.42M
MLCO icon
2983
Melco Resorts & Entertainment
MLCO
$1.8B
– –
-25,200
Closed -$193K
DFTX
2984
Definium Therapeutics
DFTX
$4.86B
– –
-1,966
Closed -$33K
MXCT icon
2985
MaxCyte
MXCT
$121M
– –
-37,018
Closed -$259K
NET icon
2986
PUT
Cloudflare
NET
$124B
– –
-13,900
Closed -$1.66M
NRIM icon
2987
Northrim BanCorp
NRIM
$556M
– –
-21,308
Closed -$232K
NVDA icon
2988
PUT
NVIDIA
NVDA
$5.43T
– –
-126,000
Closed -$3.44M
ODC icon
2989
Oil-Dri
ODC
$1.28B
– –
-229,668
Closed -$3.29M
OFLX icon
2990
Omega Flex
OFLX
$258M
– –
-2,678
Closed -$348K
PAGS icon
2991
PagSeguro Digital
PAGS
$2.49B
– –
-74,852
Closed -$1.5M
PTGX icon
2992
Protagonist Therapeutics
PTGX
$9.18B
– –
-300,468
Closed -$7.12M
RCEL icon
2993
Avita Medical
RCEL
$366M
– –
-11,290
Closed -$96K
REPX icon
2994
Riley Exploration Permian
REPX
$898M
– –
-29,182
Closed -$732K
RGLS
2995
DELISTED
Regulus Therapeutics
RGLS
– –
-18,460
Closed -$55K
RICK icon
2996
RCI Hospitality Holdings
RICK
$211M
– –
-3,578
Closed -$220K
RYZ
2997
Ryerson Holding Corp
RYZ
$1.24B
– –
-5,777
Closed -$202K
RYTM icon
2998
Rhythm Pharmaceuticals
RYTM
$6.79B
– –
-12,900
Closed -$149K
SPY icon
2999
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$796B
– –
-50,100
Closed -$22.6M
TASK icon
3000
TaskUs
TASK
$752M
– –
-8,300
Closed -$319K

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.